$MORN

Mansueto Joseph D sold $2.9M of MORN

Mansueto Joseph D (Executive Chairman) sold 14,500 shares of Morningstar, Inc. (MORN) at an average of $202.40 ($197.06–$209.38, $2.93M total) across 12 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mansueto Joseph D
Published Aug 14, 2026, 9:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MORN
Neutral
medium confidence
Mentioned
$MORN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MORNNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity and the execution price range, but it does not include any new guidance, deal, or regulatory development.

02

Market read

Traders may monitor for sentiment effects from insider selling, but the 10b5-1 structure makes it less likely to be a fundamental catalyst.

03

What to watch

The filing does not reveal why the sale occurred, and 10b5-1 plans are often routine; traders should compare with prior insider activity and total insider ownership trends.

Relevance 5/10Novelty 5/10Timing: filed 2026-08-14, covering sales executed 2026-08-13 to 2026-08-14

Background

This is an SEC Form 4 insider transaction by Morningstar’s Executive Chairman, reported as an open-market sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$MORNNeutralMedium confidence
Context

Morningstar executive chairman Mansueto Joseph D sold about 14,500 shares for roughly $2.93M across 12 trades under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction would be more about optics than new fundamentals.

Evidence & confidence

Form 4 discloses transaction size, price range, and 10b5-1 pre-arrangement, but provides no new company-specific operating or guidance information.

Market effects

Minimal, as this is a single-company insider sale without sector-wide regulatory or earnings implications.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, unusually large or clustered sales can still pressure sentiment if investors interpret it as reduced confidence.

Key entities

  • Morningstar, Inc.

    Company whose shares were sold by an executive chairman under a 10b5-1 plan.

  • Mansueto Joseph D

    Executive Chairman, Officer, Director, and 10% Owner who sold shares via multiple trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BOWMed

Morningstar DBRS Comments on Bowhead Specialty Holdings, Inc.'s Definitive Agreement to Be Acquired by American Family Insurance

Morningstar DBRS said American Family Mutual Insurance will acquire Bowhead Specialty Holdings under a definitive agreement, and the deal should not change Bowhead’s credit ratings or trends. DBRS cited American Family’s improving 2025 statutory net income of $3.2B and expects broader resources and distribution. Transaction values Bowhead at about $1.2B, expected to close before end-2026.

$MORNMedAI 8/10

Morningstar, Inc. (MORN): Results of Operations and Financial Condition

Morningstar, Inc. (MORN) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release 22 West Washington Street Telephone: +1 312 696-6000 Chicago Facsimile: +1 312 696-6009 Illinois 60602 FOR IMMEDIATE RELEASE Morningstar, Inc. Reports Second-Quarter 2026 Financial Results CHICAGO, July 29, 2026 - Morningstar, Inc. (Nasdaq: MORN), a leading provider

$MORNMedAI 9/10

Morningstar's Subscription Flywheel Compounds While the Stock Sits at Half Price

PitchBook, a Morningstar unit, reported Q1 2026 revenue of $172.4M (+5.3% YoY), with growth slowing and venture and corporate clients remaining soft. Morningstar Credit revenue rose 38.4% to $101.0M, with adjusted operating margin up 11.5 points to 40.8%. Consolidated Q1 organic revenue grew 7.6% to $644.8M reported, aided by CRSP’s $365M Feb close. Morningstar also accelerated buybacks: $787M in 2025 and $300M in Q1 2026, cutting diluted shares by 7.3% in 2025.

$JPMMedAI 8/10

AI is coming for Wall Street: Jon Erlichman

The article says AI agents are moving beyond chatbots to perform tasks such as reading earnings transcripts, building financial models, and completing compliance reviews. It cites Anthropic’s launch of 10 finance-focused agents and says major banks and others (JPMorgan, Goldman Sachs, Citigroup, AIG, Visa) are deploying them. It adds that data/software providers including FactSet, Thomson Reuters, S&P Global, Moody’s, and Morningstar saw share pressure.